Oliver Staley on Muck Rack

Oliver Staley Verified

London
Higher Education Reporter — Bloomberg News
As seen in:  Bloomberg News

I came to London to report about higher education but I stayed for the austerity.

Novartis Leukemia Treatment Yields High Remission Rate

bloomberg.com — A new leukemia immune treatment being developed by Novartis AG (NOVN) led to the disappearance of cancer in 90 percent of patients, a study showed. The therapy, a process that involved taking a patient's T cells and reprogramming them to hunt cancer cells, resulted in complete remission of 27 of 30 patients with acute lymphoblastic leukemia, a deadly pediatric cancer, according to the study published today by the New England Journal of Medicine.

AbbVie Reconsidering Shire Sends Inversion Targets Down

bloomberg.com — AstraZeneca Plc and other health-care companies considered to be tax-friendly takeover targets fell after U.S. pharmaceutical company AbbVie Inc. (ABBV) said it was reconsidering its $51.5 billion bid for Shire Plc. (SHP) AstraZeneca, a London-based drugmaker that spurned a takeover offer from Pfizer Inc. (PFE) this year, dropped 3.5 percent to 42.54 pounds at 9:22 a.m.

For Nobel Prize Winner Betzig, Quitting Let Best Ideas Prosper

bloomberg.com — Want to win a Nobel Prize? Quit your day job. That worked for Eric Betzig, at least, who is part of a trio of scientists recognized with the Nobel in chemistry today for devising ways for microscopes to look into the molecular hearts of living cells.

Three scientists win the Nobel prize for chemistry for advances in nanoscopy

smh.com.au — Trailblazers in nanoscopy: A screen showing the laureates of the 2014 Nobel prize for chemistry, American scientists Eric Betzig (left) and William Moerner (right) and Germany's Stefan Hell. Photo: Reuters Two Americans and a German won the Nobel prize in chemistry for work that allows optical microscopes to study cells in the tiniest molecular detail, aiding in research of diseases such as Parkinson's and Alzheimer's.

Three Scientists Win Chemistry Nobel for Nanoscopy Work

bloomberg.com — Two Americans and a German won the Nobel Prize in Chemistry today for work that allows optical microscopes to study cells in the tiniest molecular detail, aiding in research of diseases such as Parkinson's and Alzheimer's.

SAT Scores Drop in Math for Class of 2014

bloomberg.com — The high school class of 2014 turned in the lowest math scores on the SAT college-entrance exam since 2000 and the worst results to date in writing, as the test loses ground to rival ACT. The SAT is in the midst of a redesign to make the test more relevant.

Energy-Saving LED Lights Win Nobel Physics Prize

bloomberg.com — Three Japan-born scientists won the Nobel Prize in Physics for inventing blue-light emitting diodes, also known as energy-saving LED lights. Isamu Akasaki, 85, from Meijo and Nagoya Universities, Hiroshi Amano, 54, from Nagoya and Shuji Nakamura, 60, from the University of California at Santa Barbara, will share the 8 million-krona ($1.1 million) prize, the Royal Swedish Academy of Sciences said today in Stockholm.

AstraZeneca Whale Racing With Minnow to Develop Lung Cancer Drug

bloomberg.com — The race to develop a new class of lung-cancer medicines is pitting one of the world's biggest drugmakers against a five-year-old startup. AstraZeneca Plc (AZN), the U.K.'s second-largest pharmaceutical company, and Clovis Oncology Inc. (CLVS) of Boulder, Colorado, both intend to seek approval from regulators next year.

Roche Drug Mixtures Shown Effective in Breast and Skin Cancers

bloomberg.com — Mixing drugs in various combinations has given Roche Holding AG (ROG) effective new treatments for skin and breast cancer strains. Combining Zelboraf, a melanoma drug now on the market, with experimental cobimetinib showed significant improvement over Zelboraf alone, according to data presented today at the European Society for Medical Oncology's annual meeting in Madrid.

Glaxo Said Planning to Name RBS’s Hampton as Chairman

bloomberg.com — GlaxoSmithKline Plc (GSK) will name Philip Hampton, chairman of the Royal Bank of Scotland Plc, as its non-executive chairman by this weekend, according to people with knowledge of the matter. He will replace Christopher Gent, who has served on the Glaxo board since 2005, said the people, who asked not to be identified because the appointment hasn't been announced yet.
More Articles →
Oct 18, 2014

RT @freakonomics: How to pronounce "Tesla"? We follow lead of Tesla Motors founder Elon Musk: "TEZ-luh." ow.ly/CRNmI #RememberNikola

Oct 17, 2014

Who's going to be bold and call Ron Klain a Tsar?

Oct 17, 2014

Sheelah Kolhathar @sheelahk is reporting @BloombergNews is reporting that Mark Cuban is reporting that he's buying Netflix shares on Twitter

Oct 17, 2014

RT @FayCortez: Ebola czar is a lawyer and U.S. political guy? No international or medical background? The folly continues.

Oct 17, 2014

RT @DouthatNYT: They were going to call him the Ebola caliph, but ...


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Oliver Staley, email ostaley@muckrack.com.


Share This Profile